- Global Pharma News & Resources

Need for Accurate Treatment of Chronic Illnesses Drives Robotic Catheterization Systems Market, Says FMI

The healthcare sector showcased slight procrastination in embracing robotics, primarily due to slow uptake of regulatory bodies. With increasing prominence of skilled technicians and persisting trend of automation in across sectors, robotics is creating leeway into healthcare arena over the years. Robotic catheterization system, a product of healthcare robotics, is among the predominant minimally invasive techniques employed in peripheral and coronary intervention procedures.

Clinical research opine that robot catheterization systems exhibit decrement of ionizing radiation exposure by about 95%. Surging prevalence of cardiovascular disorders (CVD) in tandem with favorable government regulations are boosting the North America robotic catheterization systems market. As per FMI, the global robot catheterization systems market is anticipated to progress at worthwhile CAGR of ~16% over forecast period (2019-2029).

Download the Sample copy of Report with Table of Contents and Figures @

Surging Adoption in ASCs and Catheterization Labs

As per FMI, nonhospital-provider services, such as cath labs (Catheterization Laboratories), and ambulatory surgical centers (ASCs), are expected to hold significant share of robotic catheterization systems market by 2029 end. Out-of-Hospital cardiac arrest (OHCA) is one of the major reasons of demises and abnormality across the globe, particularly in developing nations. Cardiac arrest can occur regardless of time and location, as such, survival relies on prompt and proper supervision of healthcare specialists.

ASCs and catheterization laboratories are gaining wide acceptance for doing outpatient surgeries against the backdrop of shorter visits, and reduced surgery duration. In addition, medical settings in Europe are approaching service providers to set up and operate their catheterization laboratories for shifting capital expenditure to operational expenditure.

Preview Analysis of 2019 Review and Analysis of Robotic Catheterization Systems Market by Product Electromechanical Robotic Catheterization Systems and Magnetic-Guided Robotic Catheterization Systems for 2019 – 2029:

Prevalence of Robot-Assisted PCI Blooms

Coronary artery disease (CAD) is one of the most common causes of mortality, with acute STEMI (ST-elevation myocardial infarction) leading the pack. Percutaneous coronary intervention (PCI) remains a highly preferred intervention technique for reperfusion in patients suffering from STEMI. Since the inception of PCI about five decades back, the healthcare space has been observing tectonic shift in management and results of cardiovascular disease (CVD).

As robotics making inroads into the healthcare demesne, robot-assisted PCI is becoming primary solution for treatment of CAD.  Driven by medical robotics, surgical robotics are expected to witness surging traction among interventionalists, thereby fueling the adoption of robotic PCI throughout the period of projection. 

Buy this report @

Analysts at FMI suggest that “Concerns apropos efficient and timely treatment have been hovering the healthcare industry. Citing the prevalence of chronic illnesses, innovators are going back to drawing board to deliver interventional surgery solutions with minimal radiation exposure. With robotics disrupting medical centers, robotic catheterization systems market is poised to follow a positive growth trail.”

Our advisory services are aimed at helping you with specific, customized insights that are relevant to your specific challenges. Let us know about your challenges and our trusted advisors will connect with you:

More Related reports from Healthcare, Pharmaceuticals and Medical devices Market Insights:

Editor Details

Last Updated: 03-Mar-2021